STIMULATION OF E2F1/DP1 TRANSCRIPTIONAL ACTIVITY BY MDM2 ONCOPROTEIN

被引:450
作者
MARTIN, K
TROUCHE, D
HAGEMEIER, C
SORENSEN, TS
LATHANGUE, NB
KOUZARIDES, T
机构
[1] WELLCOME CRC INST,CAMBRIDGE CB2 1QR,ENGLAND
[2] UNIV CAMBRIDGE,DEPT PATHOL,CAMBRIDGE,ENGLAND
[3] NATL INST MED RES,MRC,LONDON NW7 1AA,ENGLAND
基金
英国惠康基金;
关键词
D O I
10.1038/375691a0
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
THE MDM2 proto-oncogene is found amplified in a variety of tumours(1). The oncogenic capacity of the MDM2 protein is attributed to its ability to bind the p53 tumour-suppressor protein and mask its transcriptional activation potential(2,3). Here we show that MDM2 makes a functional contact with two cooperating transcription factors, E2F1 and DP1 (refs 4, 5), which are involved in S-phase progression(6). MDM2 contacts the activation domain of E2F1 using residues conserved in the activation domain of p53. However, in contrast to its repression of p53 activity, MDM2 stimulates the activation capacity of E2F1/DP1. These results indicate that MDM2 not only releases a proliferative block by silencing the tumour suppressor p53, it also positively augments proliferation by stimulating the S-phase inducing transcription factors E2F1/DP1.
引用
收藏
页码:691 / 694
页数:4
相关论文
共 21 条
  • [1] SUPPRESSION OF HUMAN COLORECTAL-CARCINOMA CELL-GROWTH BY WILD-TYPE-P53
    BAKER, SJ
    MARKOWITZ, S
    FEARON, ER
    WILLSON, JKV
    VOGELSTEIN, B
    [J]. SCIENCE, 1990, 249 (4971) : 912 - 915
  • [2] FUNCTIONAL SYNERGY BETWEEN DP-1 AND E2F-1 IN THE CELL CYCLE-REGULATING TRANSCRIPTION FACTOR DRTF1/E2F
    BANDARA, LR
    BUCK, VM
    ZAMANIAN, M
    JOHNSTON, LH
    LATHANGUE, NB
    [J]. EMBO JOURNAL, 1993, 12 (11) : 4317 - 4324
  • [3] DP-1 - A CELL-CYCLE-REGULATED AND PHOSPHORYLATED COMPONENT OF TRANSCRIPTION FACTOR DRTF1/E2F WHICH IS FUNCTIONALLY IMPORTANT FOR RECOGNITION BY PRB AND THE ADENOVIRUS E4-ORF-6/7 PROTEIN
    BANDARA, LR
    LAM, EWF
    SORENSEN, TS
    ZAMANIAN, M
    GIRLING, R
    LATHANGUE, NB
    [J]. EMBO JOURNAL, 1994, 13 (13) : 3104 - 3114
  • [4] THE TUMOR-SUPPRESSOR P53 AND THE ONCOPROTEIN SIMIAN VIRUS-40 T-ANTIGEN BIND TO OVERLAPPING DOMAINS ON THE MDM2 PROTEIN
    BROWN, DR
    DEB, S
    MUNOZ, RM
    SUBLER, MA
    DEB, SP
    [J]. MOLECULAR AND CELLULAR BIOLOGY, 1993, 13 (11) : 6849 - 6857
  • [5] E2F-1-MEDIATED TRANSACTIVATION IS INHIBITED BY COMPLEX-FORMATION WITH THE RETINOBLASTOMA SUSCEPTIBILITY GENE-PRODUCT
    FLEMINGTON, EK
    SPECK, SH
    KAELIN, WG
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (15) : 6914 - 6918
  • [6] THE RETINOBLASTOMA PROTEIN BINDS E2F RESIDUES REQUIRED FOR ACTIVATION IN-VIVO AND TBP BINDING IN-VITRO
    HAGEMEIER, C
    COOK, A
    KOUZARIDES, T
    [J]. NUCLEIC ACIDS RESEARCH, 1993, 21 (22) : 4998 - 5004
  • [7] PHYSICAL AND FUNCTIONAL INTERACTION BETWEEN WILD-TYPE P53 AND MDM2 PROTEINS
    HAINES, DS
    LANDERS, JE
    ENGLE, LJ
    GEORGE, DL
    [J]. MOLECULAR AND CELLULAR BIOLOGY, 1994, 14 (02) : 1171 - 1178
  • [8] HETERODIMERIZATION OF THE TRANSCRIPTION FACTORS E2F-1 AND DP-1 LEADS TO COOPERATIVE TRANSACTIVATION
    HELIN, K
    WU, CL
    FATTAEY, AR
    LEES, JA
    DYNLACHT, BD
    NGWU, C
    HARLOW, E
    [J]. GENES & DEVELOPMENT, 1993, 7 (10) : 1850 - 1861
  • [9] A CDNA-ENCODING A PRB-BINDING PROTEIN WITH PROPERTIES OF THE TRANSCRIPTION FACTOR E2F
    HELIN, K
    LEES, JA
    VIDAL, M
    DYSON, N
    HARLOW, E
    FATTAEY, A
    [J]. CELL, 1992, 70 (02) : 337 - 350
  • [10] INHIBITION OF E2F-1 TRANSACTIVATION BY DIRECT BINDING OF THE RETINOBLASTOMA PROTEIN
    HELIN, K
    HARLOW, E
    FATTAEY, A
    [J]. MOLECULAR AND CELLULAR BIOLOGY, 1993, 13 (10) : 6501 - 6508